Related Experiment Video

Updated: May 31, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Vancomycin: a 50-something-year-old antibiotic we still don't understand

Amy Schilling1, Elizabeth Neuner, Susan J Rehm

  • 1Department of Infectious Disease, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Cleveland Clinic Journal of Medicine
|July 5, 2011
PubMed

Insights

Vancomycin is crucial for treating infections caused by bacteria resistant to beta-lactam antibiotics. Proper dosing and monitoring of vancomycin trough levels are essential for effective treatment and managing toxicity.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Increasing resistance of Staphylococcus aureus and coagulase-negative staphylococci to penicillin and beta-lactam antibiotics necessitates alternative treatments.
  • Vancomycin and related antibiotics are critical in managing infections caused by these resistant bacterial strains.

Purpose of the Study:

  • To highlight the importance of vancomycin in the face of rising antibiotic resistance.
  • To emphasize the need for optimized vancomycin dosing and therapeutic drug monitoring.
  • To underscore the necessity for clinicians to stay informed about vancomycin efficacy, susceptibility, and toxicity.

Main Methods:

  • Review of current clinical guidelines and literature on vancomycin usage.
  • Analysis of resistance patterns in Staphylococcus aureus and coagulase-negative staphylococci.
  • Discussion of pharmacokinetic and pharmacodynamic principles relevant to vancomycin therapy.

Main Results:

  • Vancomycin remains a cornerstone antibiotic for treating infections caused by beta-lactam-resistant Gram-positive bacteria.
  • Therapeutic drug monitoring, specifically targeting vancomycin trough levels, is vital for optimizing efficacy and minimizing toxicity.
  • Evolving definitions of vancomycin susceptibility and new interpretations of efficacy data require continuous clinician education.

Conclusions:

  • Effective management of resistant bacterial infections relies heavily on appropriate vancomycin utilization.
  • Clinicians must be vigilant regarding vancomycin dosing, therapeutic drug monitoring, and potential toxicities.
  • Staying abreast of the latest research on vancomycin susceptibility and efficacy is paramount for patient care.

More Related Videos

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...